Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4 to reflect a newer page build. This indicates a minor maintenance/patch applied to the page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe footer revision label was updated from v3.6.3 to v3.6.4, indicating a new site release rather than a change to study details or functionality.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a minor site update without changes to the study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now displays an updated revision identifier (v3.6.2), replacing the previous v3.6.0, indicating a minor platform version update.SummaryDifference0.1%

- Check66 days agoChange DetectedThe study page now shows recruitment status as 'No longer looking for participants', and adds help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The 'Intervention/Treatment' heading formatting has changed and the site revision tag updated to v3.6.0.SummaryDifference0.4%

- Check73 days agoChange DetectedAn administrative revision update was applied, replacing v3.5.4 with v3.5.5 on the page. This change does not modify any study content, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.